We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Test Results of Fingerstick Blood Vary Significantly

By LabMedica International staff writers
Posted on 29 Nov 2015
Print article
Image: Blood obtained via fingerstick is commonly used in point-of-care assays (Photo courtesy of The Health).
Image: Blood obtained via fingerstick is commonly used in point-of-care assays (Photo courtesy of The Health).
Blood obtained via fingerstick is commonly used in point-of-care assays, but few studies have assessed variability in parameters obtained from successive drops of fingerstick blood, which may cause problems for clinical decision making and for assessing accuracy of point-of-care tests.

The most accurate way to carry out medial laboratory tests is to draw blood from a vein and send it to a laboratory but sometimes, such as in low-resource settings, results are needed more rapidly, or the health professional is not trained to draw vein-blood, or there is no laboratory. In such settings, there is a higher reliance on fingerstick tests.

Bioengineers at Rice University (Houston, TX, USA) used a hematology analyzer to analyze the hemoglobin concentration, total white blood cell (WBC) count, three-part WBC differential, and platelet count in six successive 20 µL of blood collected from one fingerstick from each of 11 donors. The team used a hemoglobinometer to measure the hemoglobin concentration of 10 drops of fingerstick blood from each of seven donors to check whether the minimum droplet size made a difference and they checked all the results against blood taken from donors' veins. They also followed best practice to ensure accurate results. For example, they wiped away the first droplet to remove traces of disinfectant, and they did not squeeze or "milk" the finger.

The results showed that hemoglobin content, platelet count and white blood cell count varied significantly from drop to drop. The average percent coefficient of variation (CV) for successive drops of fingerstick blood was higher by up to 3.4 times for hemoglobin, 5.7 times for WBC count, three times for lymphocyte count, 7.7 times for granulocyte count, and four times for platelets than in venous controls measured using a hematology analyzer. The average percent CV for fingerstick blood was up to five times higher for hemoglobin than venous blood measured using a point-of-care hemoglobinometer. The investigators found that averaging the results of six to nine successive droplet tests produced results on a par with the venous blood tests.

Meaghan M. Bond, a doctoral student and first author of the study, said, “In some donors, the hemoglobin concentration changed by more than 2 g/dL in the span of two successive drops of blood. Our results show that people need to take care to administer fingerstick tests in a way that produces accurate results because accuracy in these tests is increasingly important for diagnosing conditions like anemia, infections and sickle-cell anemia, malaria, HIV and other diseases.” The study was published on November 18, 2015, in the American Journal of Clinical Pathology.

Related Links:

Rice University


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
New
PSA Test
Humasis PSA Card

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.